硕世生物
(688399)
| 流通市值：46.29亿 | | | 总市值：46.29亿 |
| 流通股本：5667.01万 | | | 总股本：5667.01万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,203,437,423.04 | 1,620,001,671.49 | 2,293,637,428.8 | 1,769,363,902.73 |
| 应收票据及应收账款 | 62,232,833.69 | 72,187,067.29 | 75,306,413.86 | 108,714,894.8 |
| 其中：应收票据 | 2,324,734 | 825,796 | 1,263,808.8 | - |
| 应收账款 | 59,908,099.69 | 71,361,271.29 | 74,042,605.06 | 108,714,894.8 |
| 预付款项 | 22,654,202.92 | 24,054,137.48 | 16,314,165.03 | 16,997,270.68 |
| 其他应收款合计 | 5,989,838.72 | 6,082,990.79 | 6,824,761.01 | 7,187,055.58 |
| 存货 | 100,168,273.87 | 98,998,370.43 | 104,248,482.78 | 93,859,936.04 |
| 其他流动资产 | 30,270,062.94 | 15,954,511.33 | 18,132,324.6 | 18,841,187.66 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,295,669,155.72 | 2,710,475,529.63 | 2,854,816,048.3 | 2,709,774,293.97 |
| 非流动资产: | | | | |
| 长期股权投资 | 111,407,181.63 | 110,605,582.88 | 111,795,746 | 112,642,154.12 |
| 其他非流动金融资产 | 332,476,884.97 | 290,859,708.73 | 302,797,944.92 | 303,832,855.42 |
| 固定资产 | 573,905,153.88 | 580,160,639.84 | 586,931,591.59 | 595,806,182.99 |
| 在建工程 | 2,800,498 | 2,111,518 | 2,061,518 | 1,532,678 |
| 使用权资产 | 15,488,609.35 | 9,910,329.17 | 14,225,449.87 | 17,274,551.6 |
| 无形资产 | 28,046,343.87 | 26,341,187.74 | 29,328,043.4 | 29,884,997.83 |
| 长期待摊费用 | 38,807,490.49 | 45,337,416.15 | 50,654,332.97 | 55,119,449.48 |
| 递延所得税资产 | 75,197,311.79 | 77,154,544 | 80,482,714.29 | 80,389,174.86 |
| 其他非流动资产 | 383,068,148.75 | 151,256,916.66 | 157,098 | 157,088 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,561,197,622.73 | 1,293,737,843.17 | 1,178,434,439.04 | 1,196,639,132.3 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,856,866,778.45 | 4,004,213,372.8 | 4,033,250,487.34 | 3,906,413,426.27 |
| 流动负债: | | | | |
| 短期借款 | 312,109,902.21 | 309,108,110.43 | 310,043,171.55 | 156,942,328.54 |
| 应付票据及应付账款 | 19,773,439.23 | 19,277,079.17 | 42,668,771.42 | 75,024,135.61 |
| 应付账款 | 19,773,439.23 | 19,277,079.17 | 42,668,771.42 | 75,024,135.61 |
| 合同负债 | 34,676,729.83 | 33,738,874.96 | 15,680,512.17 | 14,460,558.98 |
| 应付职工薪酬 | 19,351,335.39 | 21,505,308.67 | 25,713,643.77 | 42,014,938.36 |
| 应交税费 | 1,683,808.67 | 1,755,915.44 | 1,016,473.65 | 2,642,301.78 |
| 其他应付款合计 | 48,615,626.27 | 52,672,420.13 | 53,899,061.89 | 64,558,437.86 |
| 一年内到期的非流动负债 | 5,405,101.23 | 5,286,295.37 | 5,366,389.84 | 7,817,452.83 |
| 其他流动负债 | 1,014,644.11 | 986,630.81 | 439,658.13 | 408,900.42 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 442,630,586.94 | 444,330,634.98 | 454,827,682.42 | 363,869,054.38 |
| 非流动负债: | | | | |
| 租赁负债 | 8,914,780.82 | 3,851,063.8 | 8,591,978.21 | 8,695,784.56 |
| 长期应付职工薪酬 | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| 预计负债 | - | - | - | 501,296.75 |
| 递延收益 | 68,322,478.32 | 71,687,249.01 | 74,466,934.85 | 78,240,541.93 |
| 递延所得税负债 | - | - | 192,028.74 | 2,843.54 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 127,237,259.14 | 125,538,312.81 | 133,250,941.8 | 137,440,466.78 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 569,867,846.08 | 569,868,947.79 | 588,078,624.22 | 501,309,521.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 58,620,000 | 58,620,000 | 58,620,000 | 58,620,000 |
| 资本公积 | 808,398,727.5 | 806,598,045.45 | 806,598,045.45 | 806,598,045.45 |
| 减:库存股 | 147,020,312.08 | - | - | - |
| 盈余公积 | 29,310,000 | 29,310,000 | 29,310,000 | 29,310,000 |
| 未分配利润 | 2,537,690,516.95 | 2,539,816,379.56 | 2,550,643,817.67 | 2,510,575,859.66 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,286,998,932.37 | 3,434,344,425.01 | 3,445,171,863.12 | 3,405,103,905.11 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,286,998,932.37 | 3,434,344,425.01 | 3,445,171,863.12 | 3,405,103,905.11 |
| 负债和股东权益合计 | 3,856,866,778.45 | 4,004,213,372.8 | 4,033,250,487.34 | 3,906,413,426.27 |
| 公告日期 | 2024-10-26 | 2024-08-31 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |